Methotrexate and Splinter haemorrhages - a phase IV clinical study of FDA data

Summary:

Splinter haemorrhages is reported as a side effect among people who take Methotrexate (methotrexate sodium), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Remicade, and have Psoriasis.

The phase IV clinical study analyzes which people have Splinter haemorrhages when taking Methotrexate. It is created by eHealthMe based on reports of 599,650 people who have side effects when taking Methotrexate from the FDA, and is updated regularly.

What is Methotrexate?

Methotrexate has active ingredients of methotrexate sodium. It is often used in rheumatoid arthritis. eHealthMe is studying from 604,312 Methotrexate users. Check the latest studies of Methotrexate.

What is Splinter haemorrhages?

Splinter haemorrhages (tiny blood clots that tend to run vertically under the nails) is found to be associated with 17 drugs and 65 conditions by eHealthMe. Check the latest studies of Splinter haemorrhages.

On Jul, 15, 2026

599,650 people reported to have side effects when taking Methotrexate.
Among them, 11 people (0.0%) have Splinter haemorrhages.

Could Methotrexate cause Splinter haemorrhages?

Among these 11 people:

How long have people been on Methotrexate when they have Splinter haemorrhages? *

What is the gender of people who have Splinter haemorrhages when taking Methotrexate? *

female: 20 %
male: 80 %

What is the age of people who have Splinter haemorrhages when taking Methotrexate? *

What are other drugs people take besides Methotrexate? *

Remicade: 4 people, 36.36%
Paracetamol: 3 people, 27.27%
Folic Acid: 2 people, 18.18%
Calcium: 2 people, 18.18%
Solu-Medrol: 1 person, 9.09%
Simvastatin: 1 person, 9.09%
Prednisolone: 1 person, 9.09%
Hydroxychloroquine Sulfate: 1 person, 9.09%
Enbrel: 1 person, 9.09%
Cyclophosphamide: 1 person, 9.09%

What are other side effects people have besides Splinter haemorrhages? *

Drug Ineffective: 8 people, 72.73%
Nail Abnormalities (abnormal nail): 6 people, 54.55%
Nail Disorder (disease of nail): 6 people, 54.55%
Prostate Cancer: 6 people, 54.55%
Vasculitis (inflammation of a blood vessel or blood vessels): 3 people, 27.27%
Hepatic Enzyme Increased: 3 people, 27.27%
Malaise (a feeling of general discomfort or uneasiness): 2 people, 18.18%
Cholangiocarcinoma (a cancer that forms glands or secretes significant amounts of mucins): 2 people, 18.18%
Pleural Effusion (water on the lungs): 2 people, 18.18%
Osteoporosis (bones weak and more likely to break): 2 people, 18.18%

What are the existing conditions these people have? *

Psoriasis (immune-mediated disease that affects the skin): 6 people, 54.55%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 18.18%
Wegener's Granulomatosis (inflammation of the blood vessels lungs sinuses): 1 person, 9.09%
Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 9.09%
High Blood Pressure: 1 person, 9.09%
Heart Attack: 1 person, 9.09%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Methotrexate and have Splinter haemorrhages?

- Check whether Splinter haemorrhages is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Methotrexate:

Methotrexate (604,312 reports)

Browse all side effects of Methotrexate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Splinter haemorrhages:

Splinter haemorrhages (17 drugs)

Browse all the conditions that are associated with Splinter haemorrhages:

Splinter haemorrhages (65 conditions)

Related publications that referenced our studies

Henien M, Carey B, Hullah E, Sproat C, Patel V, "methotrexate-associated osteonecrosis of the jaw: A report of two cases", Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2017 Dec .
Henien M, Carey B, Hullah E, Sproat C, Patel V, "methotrexate-associated osteonecrosis of the jaw: A report of two cases", Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2017 Dec .

How the study uses the data?

The study uses data from the FDA. It is based on methotrexate sodium (the active ingredients of Methotrexate) and Methotrexate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.